Are you a Health Professional? Jump over to the doctors only platform. Click Here

A randomized dose-finding phase ll study on ifosfamide

Print Friendly, PDF & Email

A randomized dose-finding phase ll study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC)

Click on the attachement for full details!


Print Friendly, PDF & Email

Dates

Posted On: 27 February, 2004
Modified On: 3 December, 2013

Tags



Created by: myVMC